Skip to main content
OpenTrials

Clinical trial condition

Lymphatic Diseases

Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

8,991 public trials 1,838 recruiting studies
Refine in advanced search Browse all conditions

Lymphatic Diseases trial results

Completed

ACP-196 (Acalabrutinib) in Combination With Pembrolizumab, for Treatment of Hematologic Malignancies

NCT02362035

Conditions
Blood Protein Disorders, Burkitt Lymphoma, CLL, +47 more
Locations
  • Research Site Tucson, Arizona, United States
  • Research Site Los Angeles, California, United States
  • Research Site Denver, Colorado, United States
  • Research Site Washington D.C., District of Columbia, United States
View all 19 locations
View Trial Details
Completed

Allogeneic Hematopoietic Stem Cell Transplantation After Reduced-intensity Conditioning for Relapsed Follicular Lymphoma

NCT01208896

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • University Hospital Angers Angers, France
  • Service Hématologie, Hôpital Minjoz Besançon, France
  • Service Hématologie, Hôpital Augustin Morvan Brest, France
  • University Hospital, Caen Caen, France
View all 26 locations
View Trial Details
Completed

A Study Comparing the Efficacy and Safety of Polatuzumab Vedotin With Rituximab-Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab-Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Diffuse Large B-Cell Lymphoma

NCT03274492

Conditions
Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Southern Cancer Center Daphne, Alabama, United States
  • City of Hope Duarte, California, United States
  • Ronald Reagan UCLA Medical Center Los Angeles, California, United States
View all 209 locations
View Trial Details
Completed

RISE With Residents

NCT05490121

Conditions
Child Maltreatment, Domestic Violence, Education, Medical, Graduate, +13 more
Locations
  • McMaster University Hamilton, Ontario, Canada
View Trial Details
Completed

Nivolumab and the Antagonistic CSF-1R Monoclonal Antibody Cabiralizumab (BMS-986227) in Patients With Relapsed/Refractory Peripheral T Cell Lymphoma

NCT03927105

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States
  • Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
  • Unviersity of Wisconsin Madison, Wisconsin, United States
View Trial Details

Related conditions